Edge Capital Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$8.11M Sell
10,509
-1,435
-12% -$1.19M 0.36% 61
2024
Q3
$10.6M Sell
11,944
-1,569
-12% -$1.41M 0.47% 44
2024
Q2
$12.2M Sell
13,513
-54
-0.4% -$43.2K 0.59% 38
2024
Q1
$10.6M Sell
13,567
-415
-3% -$295K 0.52% 43
2023
Q4
$8.15M Buy
13,982
+530
+4% +$309K 0.45% 49
2023
Q3
$7.23M Sell
13,452
-4,467
-25% -$2.3M 0.47% 51
2023
Q2
$8.4M Buy
17,919
+891
+5% +$374K 0.48% 51
2023
Q1
$5.85M Buy
17,028
+3,390
+25% +$1.14M 0.36% 62
2022
Q4
$4.99M Buy
13,638
+652
+5% +$231K 0.35% 65
2022
Q3
$4.2M Buy
12,986
+261
+2% +$82.7K 0.35% 65
2022
Q2
$4.13M Buy
12,725
+628
+5% +$189K 0.36% 63
2022
Q1
$3.46M Buy
12,097
+1,498
+14% +$386K 0.24% 85
2021
Q4
$2.93M Buy
10,599
+26
+0.2% +$6.59K 0.21% 92
2021
Q3
$2.44M Sell
10,573
-7,245
-41% -$1.79M 0.19% 93
2021
Q2
$4.09M Buy
17,818
+523
+3% +$105K 0.33% 66
2021
Q1
$3.23M Buy
17,295
+658
+4% +$129K 0.27% 75
2020
Q4
$2.81M Buy
16,637
+4,154
+33% +$620K 0.24% 79
2020
Q3
$1.85M Buy
+12,483
New +$1.93M 0.18% 92

Other funds holding LLY

Edge Capital Group's LLY Position: Q4 2024 in Review

Edge Capital Group reduced its Eli Lilly (LLY) stake by 12% in Q4 2024, selling an estimated $1.19M and leaving 10,509 shares worth $8.11M. The position accounts for 0.36% of the portfolio, ranked #61.

Edge Capital Group first reported a position in LLY in Q3 2020 and has held it in 18 quarters since. The position peaked at $12.2M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Edge Capital Group held 10,509 shares of Eli Lilly worth $8.11M as of Q4 2024.
  • Edge Capital Group sold 1,435 Eli Lilly shares in Q4 2024, an estimated $1.19M.
  • Eli Lilly made up 0.36% of Edge Capital Group's portfolio in Q4 2024, its #61 holding.
  • Edge Capital Group first reported a position in Eli Lilly in Q3 2020 and has held it in 18 quarters since.
  • Edge Capital Group's Eli Lilly position peaked at $12.2M in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Edge Capital Group's 13F filing for Q4 2024, filed 4 Feb 2025.